ClinicalTrials.gg
CompletedNCT07670689TandRTUpdated Oct 21, 2026

Recovery, Analgesia And Delirium Profiles At Laparoscopic Abdominal and Gynecologic Surgeries With Processed EEG Monitoring

An interventional study of Bispectral index monitoring in Recovery, Analgesia And Delirium Profiles At Laparoscopic Abdominal and Gynecologic Surgeries With Processed EEG Monitoring, sponsored by Cukurova University. Completed at 3 sites in Turkey (Türkiye). Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Cukurova University · Not applicable, Interventional, and Prevention

How we know

Updated Oct 21, 2026Now CompletedFirst site in Turkey (Türkiye)+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
136
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 44 studies in Delirium with a site in Turkey — 11 open to participants now, 12 under way, none of them phase 3. Delirium · Turkey.

Enrollment
3rd of 19
136 · median 65
Started
2026
with 7 others
No phase
18 of 44
7 open now
Registered
41st of 44
by date
Lead sponsor
2 of 44
Cukurova University

Among the 44 studies in Delirium with a site in Turkey, this one is the 3rd largest by enrollment of the 19 interventional ones that give a count, is one of 8 that started in 2026, is one of 18 with no phase, and was the 41st registered.

Delirium

935 studies on the registry are indexed under Delirium; 188 are open to participants now.

Browse Delirium studies →

Open to participants now

11 of the 44 studies in Delirium with a site in Turkey are open now. Recruiting first, the newest first:

6 more — sign in →

All 11 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Delirium with a site in Turkey, or all of them as a file.
02

Study summary

The aim of this study is to evaluate the effects of processed electroencephalogram (pEEG) monitoring on recovery and extubation times, length of stay in the post-anesthesia care unit (PACU), postoperative pain, patient comfort, sedation, development of delirium, and length of hospital and intensive care unit stay in laparoscopic surgeries performed in the Trendelenburg (T) or reverse Trendelenburg (RT) positions.

Materials and Methods: This prospective, randomized, single-center study included a total of 136 patients will be scheduled for elective laparoscopic surgery under general anesthesia. Patients will allocated into four groups according to surgical position (Group T or Group RT) and the use of processed electroencephalogram monitoring (Group TBIS and Group RTBIS). Intraoperative depth of anesthesia will be maintained either by titration guided by processed electroencephalogram indices or according to standard clinical parameters. Extubation time, recovery time, length of stay in the PACU, postoperative pain scores, patient comfort, level of sedation, incidence of delirium, and lengths of hospital and intensive care unit stay will be recorded.

Read the detailed description

A total of 136 adult patients aged 18-75 yr, classified as American Society of Anesthesiologists (ASA) physical status I-II, and scheduled for elective laparoscopic abdominal surgery with an anticipated duration of at least 1 h will be included.

Patients will be excluded if they had a history of neuropsychiatric disorders, neuromuscular disease, severe cardiovascular or respiratory disease, upper respiratory tract infection within the preceding 14 days, body mass index (BMI) >40 kg m-², alcohol or substance abuse, previous bronchospasm, anticipated difficult tracheal intubation, previous tracheostomy, laryngeal disease or surgery, ASA physical status ≥III, or an actual surgical duration of less than 1 h.

Randomization and Study Groups

Patients will be randomly allocated to one of four study groups according to surgical position and use of processed electroencephalographic monitoring:

Group TBIS: Trendelenburg position with BIS monitoring. Group T: Trendelenburg position without BIS monitoring. Group RTBIS: Reverse Trendelenburg position with BIS monitoring. Group RT: Reverse Trendelenburg position without BIS monitoring. Computer-generated randomization was used for group allocation.

Haemodynamic and respiratory variables, including systolic and diastolic arterial pressure, SpO₂, ETCO₂, peak airway pressure, and BIS values, will be recorded before and after positioning in the Trendelenburg or reverse Trendelenburg position.

Demographic and perioperative data, including age, sex, height, weight, type of surgery, duration of surgery, and duration of anaesthesia, will be collected.

Extubation and recovery times, total desflurane consumption and cumulative EEG suppression time will be recorded for all patients.

PACU discharge time, pain intensity (VAS score), cumulative morphine consumption, additional analgesic (meperidine) requirements, patient comfort, and haemodynamic variables will be assessed at 15, 30, and 60 min after PACU admission.

Delirium screening will ve performed before induction of anaesthesia, at PACU admission, at PACU discharge, and twice daily thereafter (08:00 and 20:00) from postoperative day 1 through postoperative day 3, or until hospital discharge if discharge occurred earlier. Postoperative adverse events, including nausea and vomiting, respiratory depression, bradycardia, hypotension, hypertension, shivering, and urinary incontinence, will be recorded. Intensive care unit (ICU) admission, ICU length of stay, and total hospital length of stay will also be documented.

03

Conditions studied

  • Recovery, Analgesia And Delirium Profiles At Laparoscopic Abdominal and Gynecologic Surgeries With Processed EEG Monitoring

Browse trials for

Keywords

  • Processed EEG; Laparoscopic surgery; Recovery; Delirium; Depth of anesthesia
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patients aged 18-75 yr, classified as (ASA) physical status I-II, and scheduled for elective laparoscopic abdominal surgery with an anticipated duration of at least 1 h

Exclusion criteria

Exclusion Criteria:

  • if they had a history of neuropsychiatric disorders, neuromuscular disease, severe cardiovascular or respiratory disease, upper respiratory tract infection within the preceding 14 days, (BMI) >40 kg m-², alcohol or substance abuse, previous bronchospasm, anticipated difficult tracheal intubation, previous tracheostomy, laryngeal disease or surgery, ≥III, or an actual surgical duration of less than 1 h
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
136 participants (actual)

Study arms

  • Active comparator
    Group TBIS

    Trendelenburg position with BIS monitoring

    Device: Bispectral index monitoring

  • No intervention
    Group T

    Trendelenburg position without BIS monitoring

  • Active comparator
    Group RTBIS

    Reverse Trendelenburg position with BIS monitoring

    Device: Bispectral index monitoring

  • No intervention
    Group RT

    Reverse Trendelenburg position without BIS monitoring

Interventions

  • DeviceBispectral index monitoring

    Group TBIS: Trendelenburg position with BIS monitoring. Group T: Trendelenburg position without BIS monitoring. Group RTBIS: Reverse Trendelenburg position with BIS monitoring. Group RT: Reverse Trendelenburg position without BIS monitoring.

06

What researchers measure

Primary outcomes

  1. Shorter recovery times following surgery

    The primary hypothesis was that routine pEEG monitoring would be associated with shorter recovery times following surgery

    Time frame: From enrollment to the end of the study at 5 months

07

Study locations

3 sites
  • Cukurova University
    Adana, Adana 01330, Turkey (Türkiye)
  • Çukurova Üniversitesi, Tıp Fakültesi, Anesteziyoloji AD. 01130 Sarıçam, ADANA
    Adana, Adana 01330, Turkey (Türkiye)
  • Çukurova Üniversitesi, Tıp Fakültesi, Anesteziyoloji AD. 01130 Sarıçam, ADANA
    Sariçam, Adana 01330, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: Yes — "Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices), will be shared. This will include the Statistical Analysis Plan (SAP). Data will be made available to researchers who provide a methodologically sound proposal, solely to achieve aims in the approved proposal. Proposals should be directed to [hunlugenc@gmail.com]."

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report

Time frame: Data will be available beginning 6 months and ending 36 months after article publication

Access criteria: Data will be shared with qualified researchers whose proposed use has been approved by an independent review committee

Data sharing details ↗ · balcali.cu.edu.tr

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2026 to primary completion in Oct 2026, 2 months.

Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 2 months is below that.

Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: primary completion Dec 2026 → Oct 2026 and completion Jan 2027 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jun 22, 2026
First posted
Jun 26, 2026
StartActual
Jul 27, 2026
Primary completionActual
Oct 1, 2026was Dec 2026
CompletionActual
Oct 12, 2026was Jan 2027
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Completed
changed Oct 21, 2026
Sites
3 sites added — first site in Turkey (Türkiye)
Show 3 added (3 Turkey (Türkiye))
  • Cukurova University · Adana, Turkey (Türkiye)
  • Çukurova Üniversitesi, Tıp Fakültesi, Anesteziyoloji AD. 01130 Sarıçam, ADANA · Adana, Turkey (Türkiye)
  • Çukurova Üniversitesi, Tıp Fakültesi, Anesteziyoloji AD. 01130 Sarıçam, ADANA · Sariçam, Turkey (Türkiye)
Oct 21, 2026
Primary completion
Dec 27, 2026→Oct 1, 2026 (actual)
Oct 21, 2026
Study completion
Jan 15, 2027→Oct 12, 2026 (actual)
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Not yet recruiting→Completed
    3 sites added — first site in Turkey (Türkiye)
    Show 3 added (3 Turkey (Türkiye))
    • Cukurova University · Adana, Turkey (Türkiye)
    • Çukurova Üniversitesi, Tıp Fakültesi, Anesteziyoloji AD. 01130 Sarıçam, ADANA · Adana, Turkey (Türkiye)
    • Çukurova Üniversitesi, Tıp Fakültesi, Anesteziyoloji AD. 01130 Sarıçam, ADANA · Sariçam, Turkey (Türkiye)
    Primary completion Dec 27, 2026→Oct 1, 2026 (now actual)
    Study completion Jan 15, 2027→Oct 12, 2026 (now actual)
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07670689
Responsible party
Hakki Unlugenc (Profesor, MD, Cukurova University) — Principal investigator
First posted
Jun 26, 2026
Start date
Jul 27, 2026
Primary completion
Oct 1, 2026
Completion
Oct 12, 2026
Last update
Oct 21, 2026

Study contacts

HAKKI UNLUGENC, Professör
study director · Cukurova University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion